Although heart transplantation has been performed successfully for years, there is a significant risk in every transplant procedure that the organ will be rejected. To reduce the risk of rejection, patients are often prescribed immunosuppressant drugs (ISDs) which, in some cases, require ongoing monitoring.
Watch our webinar with renowned Cardiologist, Dr. Rohan Samson, MD, FACC, on the role of Immunoassays in the monitoring of ISD levels in heart transplant patients to maximize clinical outcomes and minimize potential toxic side effects inherent to ISD therapy.
During this webinar, you will:
- Learn about heart biology, transplantation types, statistics around transplant procedures in the U.S
- Review commonly used Immunosuppressant drugs, their mechanism of action, Indications for Use and common risks associated with ISD therapy
- Familiarize yourself with the current methods and guidelines in ISD monitoring for heart transplant patients
- Review case-studies of transplant patients on ISDs
Speaker
Dr. Samson is a Heart Failure and Transplant Cardiologist at the Rudd Heart Center at University of Louisville Health-Jewish Hospital in Louisville, Kentucky. His clinical practice is focused on the management of patients with advanced heart failure that require therapies like heart transplantation and left ventricular assist devices, cardiogenic shock, and pulmonary hypertension. Prior to his current position, he worked as an Assistant Professor and Attending Cardiologist with the Section of Cardiology at Tulane University. While at Tulane, he served as the Associate Program Director of the Cardiovascular Diseases Fellowship and the Medical Director of the Extra-Corporeal Membrane Oxygenation (ECMO) Program.
Dr. Samson earned his Bachelor of Medicine and Bachelor of Surgery (M.B.B.S) from the Govt. Kilpauk Medical College in Chennai, India. He completed his internal medicine residency at the University of Florida, Jacksonville. Thereafter, he pursued sub-specialty training in Advanced Heart Failure/Heart Transplantation at the University of Washington and Cardiovascular Diseases at Tulane University. He is board certified in Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease, and Internal Medicine.
